🔎 Trials Near Me

Home › Kanser sa Suso › Maryland › Germantown

Pag-aaral pangklinika para sa Kanser sa Suso sa Germantown, MD

Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Germantown. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • MedStar Montgomery Medical Center, Olney · 11 mi ang layo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Nagre-recruitPhase 3
  • James M Stockman Cancer Institute, Frederick · 18 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07174336

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Nagre-recruitPhase 3
  • Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · 4 mi ang layo
  • MedStar Montgomery Medical Center, Olney · 11 mi ang layo
  • FMH James M Stockman Cancer Institute, Frederick · 18 mi ang layo
Edad 18 hanggang 60 · Kababaihan · Na-update Set 2, 2026 · NCT05879926

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Nagre-recruitPhase 3
  • Inova Loudoun Hospital, Leesburg · 16 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06500481

E-Mindfulness Approaches for Living After Breast Cancer

Nagre-recruitPhase 3
  • Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · 4 mi ang layo
  • MedStar Montgomery Medical Center, Olney · 11 mi ang layo
  • Inova Loudoun Hospital, Leesburg · 16 mi ang layo
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06748222

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Nagre-recruitPhase 1/2
  • USOR Maryland Oncology Hematology, Rockville · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Nagre-recruitPhase 2
  • Maryland Oncology Hematology- Columbia, Rockville · 9 mi ang layo
Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Nagre-recruitPhase 3
  • Maryland Oncology Hematology P.A., Germantown
  • Maryland Oncology Hematology P.A., Rockville · 9 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT07062965

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Nagre-recruitObservasyonal na pag-aaral
  • James M Stockman Cancer Institute, Frederick · 18 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT06401421

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Nagre-recruitObservasyonal na pag-aaral
  • Maryland Oncology Hematology - Aquilino Cancer Center, Rockville · 9 mi ang layo
  • Frederick Oncology Hematology Associates, Frederick · 18 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2025 · NCT03053193

Pag-aaral para sa Kanser sa Suso sa ibang lungsod

Iba pang pag-aaral sa Germantown

Mula sa ClinicalTrials.gov, na-kuha noong Okt 7, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.